Sangamo Therapeutics SGMOQ
OTC SGMOQ
$0.15 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sangamo Therapeutics (SGMOQ) Cash & Equivalents (2010 - 2025)

Updated

Sangamo Therapeutics' Cash & Equivalents came in at $20.95 million for Q4 2025, down 50.0% from $41.92 million a year earlier and down 29.3% from the prior quarter.

Analysis

Sangamo Therapeutics (SGMOQ) Cash & Equivalents (2010 - 2025) Analysis & Trends

Going back to Q2 2010, Sangamo Therapeutics' Cash & Equivalents data covers 63 quarters.

  • Cash & Equivalents has declined in each of the last four years, with a five-year compound annual growth rate of -30.7% (FY2020 to FY2025).
  • Going back by year, Cash & Equivalents was $41.92 million in FY2024 (-7.3%), $45.2 million in FY2023 (-55.0%), $100.44 million in FY2022 (-43.8%) and $178.87 million in FY2021 (+36.2%).
  • The Q4 2025 figure represents the lowest quarterly Cash & Equivalents since Q1 2017.
  • Year-over-year, Cash & Equivalents increased in 1 of the last eight quarters, with an average decline of 27.1%.
  • The fastest year-over-year change in Cash & Equivalents over five years came in Q1 2021 (growth of 43.4%), and the weakest in Q2 2021 (a decline of 63.7%).
  • Business Quant data shows SGMOQ's Cash & Equivalents at $29.62 million (Q3 2025), $38.34 million (Q2 2025) and $25.2 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.42 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 976.00 Mn
10 Sangamo Therapeutics 42.03 Mn -72.08 Mn - 20.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 20.95 Mn
Sep 30, 2025 29.62 Mn
Jun 30, 2025 38.34 Mn
Mar 31, 2025 25.20 Mn
Dec 31, 2024 41.92 Mn
Sep 30, 2024 39.20 Mn
Jun 30, 2024 27.79 Mn
Mar 31, 2024 54.42 Mn
Dec 31, 2023 45.20 Mn
Sep 30, 2023 56.51 Mn
Jun 30, 2023 66.83 Mn
Mar 31, 2023 78.24 Mn
Dec 31, 2022 100.44 Mn
Sep 30, 2022 94.57 Mn
Jun 30, 2022 117.71 Mn
Mar 31, 2022 120.26 Mn
Dec 31, 2021 178.87 Mn
Sep 30, 2021 176.95 Mn
Jun 30, 2021 169.88 Mn
Mar 31, 2021 122.98 Mn
API Access

Sangamo Therapeutics Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY